251
Views
3
CrossRef citations to date
0
Altmetric
Original Research

A Retrospective Comparative Study of Two Concentrations of Intralesional Triamcinolone Acetonide in the Treatment of Patchy Alopecia Areata on the Scalp

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, &
Pages 795-803 | Published online: 02 Nov 2020

References

  • Perera E, Yip L, Sinclair R. Alopecia areata In: Alopecias-Practical Evaluation and Management. Vol. 47 Karger Publishers; 2015:67–75.
  • Gilhar A. Collapse of immune privilege in alopecia areata: coincidental or substantial? J Invest Dermatol. 2010;130:2535–2537. doi:10.1038/jid.2010.26020944635
  • Islam N, Leung PS, Huntley AC, Gershwin ME. The autoimmune basis of alopecia areata: a comprehensive review. Autoimmun Rev. 2015;14(2):81–89. doi:10.1016/j.autrev.2014.10.01425315746
  • Petukhova L, Duvic M, Hordinsky M, et al. Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature. 2010;466(7302):113–117. doi:10.1038/nature0911420596022
  • Darwin E, Hirt PA, Fertig R, Doliner B, Delcanto G, Jimenez JJ. Alopecia areata: review of epidemiology, clinical features, pathogenesis, and new treatment options. Int J Trichology. 2018;10(2):51. doi:10.4103/ijt.ijt_99_1729769777
  • Safavi K. Prevalence of alopecia areata in the First National Health and Nutrition Examination Survey. Arch Dermatol. 1992;128:702. doi:10.1001/archderm.1992.01680150136027
  • Fricke AC, Miteva M. Epidemiology and burden of alopecia areata: a systematic review. Clin Cosmet Investig Dermatol. 2015;8:397.
  • Messenger AG, McKillop J, Farrant P, et al. British Association of Dermatologists’ guidelines for the management of alopecia areata 2012. Br J Dermatol. 2012;166(5):916–926. doi:10.1111/j.1365-2133.2012.10955.x22524397
  • Pratt CH, King LE, Messenger AG, Christiano AM, Sundberg JP. Alopecia areata. Nat Rev Dis Primers. 2017;3(1):1–7. doi:10.1038/nrdp.2017.11
  • Rodgers AR. Why finding a treatment for alopecia areata is important: a multifaceted perspective. J Investig Dermatol Symp Proc. 2018;19(1):S51–S53. Elsevier. doi:10.1016/j.jisp.2017.10.008
  • Aghaei S, Saki N, Daneshmand E, Kardeh B. Prevalence of psychological disorders in patients with alopecia areata in comparison with normal subjects. Int Sch Res Notices. 2014;2014.
  • Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J. Alopecia areata update: part II. Treatment. J Am Acad Dermatol. 2010;62(2):191–202. doi:10.1016/j.jaad.2009.10.03120115946
  • Shapiro J. Current treatment of alopecia areata. J Investig Dermatol Symp Proc. 2013;16(1):S42–S44. Elsevier. doi:10.1038/jidsymp.2013.14
  • Lee S, Lee WS. Management of alopecia areata: updates and algorithmic approach. J Dermatol. 2017;44(11):1199–1211. doi:10.1111/1346-8138.1393328635045
  • Kassim JM, Shipman AR, Szczecinska W, et al. How effective is intralesional injection of triamcinolone acetonide compared with topical treatments in inducing and maintaining hair growth in patients with alopecia areata? A critically appraised topic. Br J Dermatol. 2014;170(4):766–771. doi:10.1111/bjd.1286324484438
  • Gupta AK, Carviel J, Abramovits W. Treating alopecia areata: current practices versus new directions. Am J Clin Dermatol. 2017;18(1):67–75. doi:10.1007/s40257-016-0230-427770310
  • Abell E, Munro DD. Intralesional treatment of alopecia areatawith triamcinolone acetonide by jet injector. Br J Dermatol. 1973;88:55–59. doi:10.1111/j.1365-2133.1973.tb06672.x4686543
  • Kubeyinje EP. Intralesional triamcinolone acetonide in alopecia areata amongst 62 Saudi Arabs. East Afr Med J. 1994;71:674–675.7821250
  • Devi M, Rashid A, Ghafoor R. Intralesional triamcinolone acetonide versus topical betamethasone valearate in the management of localized alopecia areata. J Coll Physicians Surg Pak. 2015;25(12):860–862.26691357
  • Kuldeep CM, Singhal H, Khare AK, Mittal A, Gupta LK, Garg A. Randomized comparison of topical betamethasone valerate foam, intralesional triamcinolone acetonide and tacrolimus ointment in management of localized alopecia areata. Int J Trichology. 2011;3(1):20. doi:10.4103/0974-7753.8212321769231
  • Chu TW, AlJasser M, Alharbi A, Abahussein O, McElwee K, Shapiro J. Benefit of different concentrations of intralesional triamcinolone acetonide in alopecia areata: an intrasubject pilot study. J Am Acad Dermatol. 2015;73(2):338–340. doi:10.1016/j.jaad.2015.04.04926183987
  • Stallings AM. ILK index and regrowth in alopecia areata. J Investig Dermatol Symp Proc. 2015;17:47–49. doi:10.1038/jidsymp.2015.27
  • Yee BE, Tong Y, Goldenberg A, Hata T. Efficacy of different concentrations of intralesional triamcinolone acetonide for alopecia areata: A systematic review and meta-analysis. J Am Acad Dermatol. 2020;82(4):1018–1021. doi:10.1016/j.jaad.2019.11.06631843657
  • Ustuner P, Balevi A, Özdemir M. Best dilution of the best corticosteroid for intralesional injection in the treatment of localized alopecia areata in adults. J Dermatol Treat. 2017;28(8):753–761. doi:10.1080/09546634.2017.1329497
  • Suchonwanit P, Kositkuljorn C, Mahasaksiri T, Leerunyakul K. A comparison of the efficacy and tolerability of three corticosteroid treatment regimens in patients with alopecia areata. J Dermatol Treat. 2020:1–21.
  • Forouzan P, Cohen PR. Systemic lupus erythematosus presenting as alopecia areata. Cureus. 2020;12(6).
  • Forouzan P, Cohen PR. Incipient diabetes mellitus and nascent thyroid disease presenting as beard alopecia areata: case report and treatment review of alopecia areata of the beard. Cureus. 2020;12(7).